BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  NexGenix Pharmaceuticals Holdings, Inc. Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference

  February 25, 2008

   · 

  2 min read
• Genetown

  Arbios Systems Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM) Primary Endpoint of the Trial to Be Clarified with FDA

  February 25, 2008

   · 

  5 min read
• Drug Development

  Alexza Pharmaceuticals, Inc. Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)

  February 25, 2008

   · 

  7 min read
• Drug Development

  GTx, Inc.'s Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy

  February 25, 2008

   · 

  8 min read
• Deals

  Elan Corporation PLC Said Mulling Technology Unit Spin-Off

  February 25, 2008

   · 

  1 min read
• Drug Development

  Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy

  February 25, 2008

   · 

  4 min read
• Drug Development

  MacuSight, Inc. Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration Sirolimus Demonstrates Favorable Safety Profile and Improvements in Visual Acuity

  February 25, 2008

   · 

  6 min read
• Genetown

  pSivida Limited to Present at Sachs Conference - Boston

  February 25, 2008

   · 

  1 min read
• Business

  Kamada Ltd. and PARI Pharma Expand Collaboration

  February 25, 2008

   · 

  1 min read
• Drug Development

  GeoVax, Inc. Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials

  February 25, 2008

   · 

  4 min read